FXR ChIP‐seq data sets from three different species are publicly available; these are five for mice,(4, 5, 6, 7, 8) one for rat,(10) one for human primary hepatocytes,(9) and one from human liver biopsy samples.(11) Data sets included baseline FXR binding and FXR binding under pharmacologic treatment (i.e., FXR activation with different ligands) or diseased conditions (i.e., diet‐induced nonalcoholic fatty liver disease or cholestasis) (Table 1; Supporting Table S1). This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.